N‐acetylcysteine as an adjuvant to clomiphene citrate for successful induction of ovulation in infertile patients with polycystic ovary syndrome
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Aim: The aim of this study was to evaluate the effect of oral N‐acetylcysteine (NAC) administration as an adjuvant to clomiphene citrate (CC) on induction of ovulation outcomes in patients with polycystic ovary syndrome (PCOS). Material and Methods: In this placebo‐controlled double‐blind randomized clinical trial, 180 PCOS infertile patients were randomly divided into two groups for induction of ovulation. Patients in group 1 received CC 100 mg/d plus NAC 1.2 g/d and patients in group 2 received CC plus placebo for 5 days starting at day 3 of the cycle. On the 12th day of the menstrual cycle in the presence of at least one follicle with an 18–20‐mm diameter in ultrasound evaluation, 10 000 U hCG was injected intramuscularly and timed intercourse was advised 36 h after hCG injection. Serum β‐hCG level was measured on the 16th day after hCG injection. Results: The number of follicles >18 mm and the mean endometrial thickness on the day of hCG administration were significantly higher among the CC+NAC group (P‐value = 0.001). The ovulation and pregnancy rates were also significantly higher in the CC+NAC group (P‐value = 0.02 and 0.04, respectively). No adverse side‐effects and no cases of ovarian hyperstimulation syndrome were observed in the group receiving NAC. Conclusion: NAC as a safe and well‐tolerated adjuvant to CC for induction of ovulation can improve the ovulation and pregnancy rates in PCOS patients. It may also have some beneficial impacts on endometrial thickness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
Goodarzi, M. O., Dumesic, D. A., Chazenbalk, G., & Azziz, R. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.217 · Cited by 1,488 · cited 1×
“Polycystic ovarian syndrome (PCOS) is the most common endocrinopathy in women of reproductive age, with a prevalence of up to 10%.(1) The diagnosis of PCOS is determined by the presence of two of the following conditions: oligo-ovulation or anovulation, hyperandrogenemia, hyperandrogenism and polycystic ovaries detect…”
BackgroundMoghetti, P., Castello, R., Negri, C., Tosi, F., Perrone, F., Caputo, M., Zanolin, E., & Muggeo, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.1.6293 · Cited by 660
Sonographic determination of a possible adverse effect of clomiphene citrate on endometrial growth
Gonen, Y., & Casper, R. F. (1990) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137165 · Cited by 193
Cited by
Antioxidants for female subfertility
Showell, M. G., Mackenzie-Proctor, R., Jordan, V., & Hart, R. J. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007807.pub4 · Cited by 119
Thakker, D., Raval, A., Patel, I., & Walia, R. (2015) · Obstetrics and Gynecology International · doi:10.1155/2015/817849 · Cited by 54
“Treatment allocation was concealed by administration of third party (nurse) using opaque sealed envelopes in four studies [14, 20–22], unclear in three studies [18, 19], and not done in one study [28].”
BackgroundMethodAkbari Sene, A., Tabatabaie, A., Nikniaz, H., Alizadeh, A., Sheibani, K., Mortezapour Alisaraie, M., Tabatabaie, M., Ashrafi, M., & Amjadi, F. (2019) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-019-05111-1 · Cited by 42
Metadata
- Authors
- Salehpour, S., Akbari Sene, A., Saharkhiz, N., Sohrabi, M. R., & Moghimian, F.
- Venue
- Journal of Obstetrics and Gynaecology Research
- Publisher
- Wiley
- Published
- 2012-04-30
- Volume
- 38
- Issue
- 9
- Pages
- 1182-1186
- ISSN
- 1341-8076 (ISSN-L)
- 1447-0756
- OpenAlex
- W1601977053
- Cited by
- 44
- References
- 3
- FWCI
- 2.62
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.